Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPBSX · Entity 1897 | Director | October 01, 2020 | October 05, 2020 |
| ILLUMINA, INC.ILMN · Entity 3137 | Director | May 16, 2024 | May 17, 2024 |
| STRYKER CORPSYK · Entity 369 | President & CEO | February 06, 2012 | February 08, 2012 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BOSTON SCIENTIFIC CORP
Report date October 01, 2020 · Filed October 05, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,000 |
Reported balance
After 2020-10-01 transaction · row 1
1 source rowRow 1 · 2020-10-01 · Grant · Acquired 498 · Balance 8,000 F1: Restricted stock granted in lieu of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $19,167, divided by the closing price of common stock on the date of grant. This grant represents the equivalent of two months of the board cash retainer as a result of board approval of the restoration of a portion of its cash compensation as disclosed on a Form 8-K dated October 5, 2020. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock granted in lieu of cash compensation, vesting in full upon the next annual meeting of stockholders. Reflects a value of $19,167, divided by the closing price of common stock on the date of grant. This grant represents the equivalent of two months of the board cash retainer as a result of board approval of the restoration of a portion of its cash compensation as disclosed on a Form 8-K dated October 5, 2020.
ILLUMINA, INC.
Report date May 16, 2024 · Filed May 17, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,129 |
Reported balance
After 2024-05-16 transaction · row 1
1 source rowRow 1 · 2024-05-16 · Grant · Acquired 2,622 · Balance 4,129 F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of restricted stock units. 100% of the shares subject to the restricted stock unit award shall vest on the earlier of (i) the one year anniversary of the date of grant of the award and (ii) the date immediately preceding the date of the annual meeting of the company's stockholders for the year following the year of grant of the award, provided, in each case, that the awardee continues to serve as a director on such date.
STRYKER CORP
Report date February 06, 2012 · Filed February 08, 2012
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 132,002 |
Reported balance
After 2012-02-06 transaction · row 1
1 source rowRow 1 · 2012-02-06 · Exercise / conversion · Acquired 5,000 · Balance 132,002 |
| Common StockSEC Table II · derivative / convertible security · Conversion / exercise price $46.85 · Expires 2016-02-06 | Direct | 0 |
Reported balance
After 2012-02-06 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2012-02-06 · Exercise / conversion · Disposed 5,000 · Balance 0 F1: Employee stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 10% on each of the first eight anniversaries of the date of grant and 20% on the ninth anniversary of the date of grant. |
| Common StockSEC Table I · non-derivative | IndirectBy 401k Plan | 716 |
Reported balance
Holding disclosure · report date 2012-02-06 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 716 |
| Common StockSEC Table I · non-derivative | IndirectAs Custodian | 200 |
Reported balance
Holding disclosure · report date 2012-02-06 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 200 |
Filing footnotes · ownership attribution and instrument terms
F1: Employee stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 10% on each of the first eight anniversaries of the date of grant and 20% on the ninth anniversary of the date of grant.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
HOLOGIC INC
Report date April 07, 2026 · Filed April 09, 2026
Section 16 reporting ended · disclosed 2026-04-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 1
1 source rowRow 1 · 2026-04-07 · Disposition to issuer · Disposed 1,423,837 · Balance 0 F1: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to Hologic's Deferred Equity Plan. F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F3: At the Effective Time, each time-vesting restricted stock unit award ("Company RSU") held by the reporting person granted before October 21, 2025 converted into the right to receive the Merger Consideration for each share of Company Common Stock underlying the Company RSU; and each Company RSU held by the reporting person granted after October 21, 2025 converted into, for each share of Company Common Stock subject to such Company RSU immediately prior to the Effective Time, (i) an unvested award representing the right to receive a cash payment equal to the Cash Consideration, and (ii) an unvested award representing the right to receive cash payments equal to the payments to the holder of one CVR, if any, pursuant to the CVR agreement, in each case, subject to the terms applied to the corresponding Company RSU immediately prior to the Effective Time. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. |
| Common StockSEC Table I · non-derivative | IndirectMacMillan Family Trust | 0 |
Reported balance
After 2026-04-07 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-04-07 · Disposition to issuer · Disposed 1,146,829 · Balance 0 F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration"). F4: As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.64 · Expires 2026-12-01 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-04-07 · Disposition to issuer · Disposed 160,565 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.85 · Expires 2027-12-01 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-04-07 · Disposition to issuer · Disposed 159,339 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.85 · Expires 2027-12-01 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-04-07 · Disposition to issuer · Disposed 768,639 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $40.97 · Expires 2028-11-12 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2026-04-07 · Disposition to issuer · Disposed 151,071 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.61 · Expires 2029-11-11 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2026-04-07 · Disposition to issuer · Disposed 152,529 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $68.35 · Expires 2030-11-09 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2026-04-07 · Disposition to issuer · Disposed 123,801 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.13 · Expires 2031-11-08 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2026-04-07 · Disposition to issuer · Disposed 118,877 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $74.35 · Expires 2032-11-07 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2026-04-07 · Disposition to issuer · Disposed 106,300 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.94 · Expires 2033-11-14 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2026-04-07 · Disposition to issuer · Disposed 117,829 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Non-qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $79.39 · Expires 2034-11-11 | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2026-04-07 · Disposition to issuer · Disposed 117,801 · Balance 0 F5: For Footnote (5), see Remarks below. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 190,400 |
Reported balance
After 2026-04-07 transaction · row 13
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 13 · 2026-04-07 · Grant · Acquired 190,400 · Balance 190,400 F6: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F7: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. |
| Performance Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2026-04-07 transaction · row 14
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 14 · 2026-04-07 · Disposition to issuer · Disposed 190,400 · Balance 0 F6: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock. F7: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 1,079,673 restricted stock units/performance stock units, the settlement of which has been deferred pursuant to Hologic's Deferred Equity Plan.
F2: Pursuant to the Agreement and Plan of Merger, dated as of October 21, 2025 (the "Merger Agreement"), by and among Hologic, Inc. ("Hologic" or "Company"), Hopper Parent Inc., a Delaware corporation ("Parent"), and Hopper Merger Sub Inc., a Delaware corporation and wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Company (the "Merger"), with the Company surviving the Merger as a wholly owned subsidiary of Parent. At the effective time of the Merger (the "Effective Time"), each share of Hologic common stock, par value $0.01 ("Company Common Stock"), was converted into the right to receive (x) $76.00 per share in cash, without interest (the "Cash Consideration") and (y) one (1) contingent value right, which represents the right to receive up to $3.00 in cash, when and if payable (each, a "CVR") (the consideration contemplated by clauses (x) and (y), together, the "Merger Consideration").
F3: At the Effective Time, each time-vesting restricted stock unit award ("Company RSU") held by the reporting person granted before October 21, 2025 converted into the right to receive the Merger Consideration for each share of Company Common Stock underlying the Company RSU; and each Company RSU held by the reporting person granted after October 21, 2025 converted into, for each share of Company Common Stock subject to such Company RSU immediately prior to the Effective Time, (i) an unvested award representing the right to receive a cash payment equal to the Cash Consideration, and (ii) an unvested award representing the right to receive cash payments equal to the payments to the holder of one CVR, if any, pursuant to the CVR agreement, in each case, subject to the terms applied to the corresponding Company RSU immediately prior to the Effective Time. As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
F4: As a result of the Merger, the reporting person no longer beneficially owns, directly or indirectly, any shares of Company Common Stock.
F5: For Footnote (5), see Remarks below.
F6: Each Hologic restricted stock unit represents a contingent right to receive one share of Company Common Stock.
F7: Represents the certification of performance results applicable to outstanding Hologic performance stock units ("PSUs") by the compensation committee of the board of directors of Hologic. Pursuant to the Merger Agreement, for purposes of determining the number of shares of Company Common Stock subject to each PSU, any applicable performance goals were deemed achieved at the greater of (A) the target level of performance and (B) the actual level of performance measured through the latest practicable date prior to the Effective Time. Pursuant to the Merger Agreement, each outstanding PSU was cancelled and converted into the right to receive the Merger Consideration in respect of each share of Company Common Stock subject to such PSU.
TEXAS INSTRUMENTS INC
Report date February 17, 2012 · Filed February 21, 2012
Section 16 reporting ended · disclosed 2012-02-21. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $1.00 | Direct | 5,899.25 |
Reported balance
After 2012-02-17 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2012-02-17 · Grant · Acquired 98.3 · Balance 5,899.25 F1: Security converts to common stock on a one-for-one basis. F2: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. |
| Common StockSEC Table I · non-derivative | Direct | 13,977 |
Reported balance
Holding disclosure · report date 2012-02-17 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 13,977 |
Filing footnotes · ownership attribution and instrument terms
F1: Security converts to common stock on a one-for-one basis.
F2: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2017 Filed Jan 5, 2017 22:50 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantDeferred Stock Units · Derivative | 771 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-000782 · doc4.xml · derivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,217 Underlying: Common Stock · 771 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · shares: Reflects a value of $16,875 divided by the closing price of common stock on the date of grant. F3 · derivative.exercise_date: Deferred stock units were granted in lieu of 75% of the quarterly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. F3 · derivative.expiration_date: Deferred stock units were granted in lieu of 75% of the quarterly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Read SEC document |
| December 13, 2016 Filed Dec 21, 2016 22:03 UTC | HOLOGIC INC HOLX · Entity 12463 | OtherCommon Stock | 7,395 | $40.52 | $299,645.40 |
DisclosureSEC source: 0001127602-16-070717 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 788,812 F1 · kind: Shares transferred pursuant to marriage settlement agreement. F2 · price: Closing price per share of Hologic stock on the date of transfer. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 21:26 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionPerformance Stock Unit Award (Right to Receive) · Derivative | 307,760 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-16-069506 · form4.xml · derivative · entry 8 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 307,760 shares Expires 2016-12-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: PSUs convert into common stock on a one-for-one basis. F4 · price: PSUs convert into common stock on a one-for-one basis. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 21:26 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantPerformance Stock Unit Award (Right to Receive) · Derivative | 150,739 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001127602-16-069506 · form4.xml · derivative · entry 7 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 307,760 Underlying: Common Stock · 150,739 shares Expires 2016-12-06 F4 · derivative.exercise_price: PSUs convert into common stock on a one-for-one basis. F4 · price: PSUs convert into common stock on a one-for-one basis. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 21:26 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionRestricted Stock Unit Award (Right To Receive) · Derivative | 28,039 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-069506 · form4.xml · derivative · entry 6 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,040 Underlying: Common Stock · 28,039 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · shares: Represents vested RSUs that are subject to deferral pursuant to the Issuer's Deferred Equity Plan and are voluntarily being reported on Table 1. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: This RSU award vests in four equal installments beginning on first anniversary of the grant date. F6 · derivative.expiration_date: This RSU award vests in four equal installments beginning on first anniversary of the grant date. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 21:26 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionRestricted Stock Unit Award (Right To Receive) · Derivative | 19,628 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-069506 · form4.xml · derivative · entry 5 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,628 Underlying: Common Stock · 19,628 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. F6 · derivative.exercise_date: This RSU award vests in four equal installments beginning on first anniversary of the grant date. F6 · derivative.expiration_date: This RSU award vests in four equal installments beginning on first anniversary of the grant date. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 21:26 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 307,760 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-069506 · form4.xml · nonDerivative · entry 4 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 796,207 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Represents vested Performance Share Units (PSUs) that are subject to deferral pursuant to the Issuer's Deferred Equity Plan. F4 · price: PSUs convert into common stock on a one-for-one basis. F5 · balance_after: Includes 353,118 shares subject to deferral pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 21:26 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 28,039 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-069506 · form4.xml · nonDerivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 488,447 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · shares: Represents vested RSUs that are subject to deferral pursuant to the Issuer's Deferred Equity Plan and are voluntarily being reported on Table 1. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 21:26 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 9,530 | $38.89 | $370,621.70 |
DisclosureSEC source: 0001127602-16-069506 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 460,408 Read SEC document |
| December 06, 2016 Filed Dec 8, 2016 21:26 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 19,628 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-069506 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 469,938 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| December 01, 2016 Filed Dec 6, 2016 00:57 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantNon-qualified Stock Option (Right to Buy) · Derivative | 160,565 | $0.00 Strike: $37.64 | $0.00 |
DisclosureSEC source: 0001127602-16-069215 · form4.xml · derivative · entry 5 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,565 Underlying: Common Stock · 160,565 shares Expires 2026-12-01 F6 · derivative.exercise_date: This option to purchase common stock becomes exercisable in equal installments on each of the first four anniversaries of the grant date. Read SEC document |
| December 01, 2016 Filed Dec 6, 2016 00:57 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 9,623 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-069215 · form4.xml · nonDerivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,310 F5 · shares: Represents Matching RSUs granted to the Reporting Person which vest in accordance with the terms of his 2015 Employment Agreement. F2 · price: RSUs convert into common stock on a one-for-one basis upon vesting. F4 · balance_after: Includes 17,319 shares subject to deferral pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| December 01, 2016 Filed Dec 6, 2016 00:57 UTC | HOLOGIC INC HOLX · Entity 12463 | GrantCommon Stock | 51,957 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-069215 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 440,687 F3 · shares: Represents RSUs which vest in equal installments on each of the first three anniversaries of the grant date and are settled in shares of common stock. F2 · price: RSUs convert into common stock on a one-for-one basis upon vesting. F4 · balance_after: Includes 17,319 shares subject to deferral pursuant to the Issuer's Deferred Equity Plan. Read SEC document |
| November 07, 2016 Filed Nov 8, 2016 22:44 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionRestricted Stock Unit Award (Right To Receive) · Derivative | 17,348 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-066428 · form4.xml · derivative · entry 3 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,696 Underlying: Common Stock · 17,348 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units (RSUs) convert into common stock on a one-for-one basis upon vesting. F1 · price: Restricted stock units (RSUs) convert into common stock on a one-for-one basis upon vesting. F2 · derivative.exercise_date: This RSU award vests in four equal installments beginning on first anniversary of the grant date. F2 · derivative.expiration_date: This RSU award vests in four equal installments beginning on first anniversary of the grant date. Read SEC document |
| November 07, 2016 Filed Nov 8, 2016 22:44 UTC | HOLOGIC INC HOLX · Entity 12463 | Tax withholdingCommon Stock | 5,965 | $38.68 | $230,726.20 |
DisclosureSEC source: 0001127602-16-066428 · form4.xml · nonDerivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,611 Read SEC document |
| November 07, 2016 Filed Nov 8, 2016 22:44 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 17,348 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-066428 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,576 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units (RSUs) convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| November 05, 2016 Filed Dec 6, 2016 00:57 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionRestricted Stock Unit Award (Right To Receive) · Derivative | 15,119 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-069215 · form4.xml · derivative · entry 4 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,238 Underlying: Common Stock · 15,119 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: RSUs convert into common stock on a one-for-one basis upon vesting. F1 · timeliness: Represents vested RSUs that are subject to deferral pursuant to the Issuer's Deferred Equity Plan and are voluntarily being reported on Table 1. F2 · price: RSUs convert into common stock on a one-for-one basis upon vesting. F3 · derivative.exercise_date: Represents RSUs which vest in equal installments on each of the first three anniversaries of the grant date and are settled in shares of common stock. F3 · derivative.expiration_date: Represents RSUs which vest in equal installments on each of the first three anniversaries of the grant date and are settled in shares of common stock. Read SEC document |
| November 05, 2016 Filed Dec 6, 2016 00:57 UTC | HOLOGIC INC HOLX · Entity 12463 | Exercise / conversionCommon Stock | 15,119 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-16-069215 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,347 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · timeliness: Represents vested RSUs that are subject to deferral pursuant to the Issuer's Deferred Equity Plan and are voluntarily being reported on Table 1. F2 · price: RSUs convert into common stock on a one-for-one basis upon vesting. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:09 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantStock Option (Right to Buy) · Derivative | 796 | $0.00 Strike: $23.50 | $0.00 |
DisclosureSEC source: 0001225208-16-040184 · doc4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 796 Underlying: Common Stock · 796 shares Expires 2026-10-03 F4 · shares: Reporting person received 25% of the cash compensation for the third quarter of 2016 in the form of an option to purchase a specified number of shares of common stock vesting in full upon the 2017 annual meeting of stockholders. F4 · derivative.exercise_date: Reporting person received 25% of the cash compensation for the third quarter of 2016 in the form of an option to purchase a specified number of shares of common stock vesting in full upon the 2017 annual meeting of stockholders. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:09 UTC | BOSTON SCIENTIFIC CORP BSX · Entity 1897 | GrantDeferred Stock Units · Derivative | 718 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-16-040184 · doc4.xml · derivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,446 Underlying: Common Stock · 718 shares Expires not disclosed F1 · derivative.exercise_price: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. F2 · shares: Reflects a value of $16,875 divided by the closing price of common stock on the date of grant. F3 · derivative.exercise_date: Deferred stock units were granted in lieu of 75% of the quarterly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. F3 · derivative.expiration_date: Deferred stock units were granted in lieu of 75% of the quarterly cash compensation and vest in full upon the next annual meeting of stockholders. Vested shares of stock will be issued to the reporting person following the reporting person's separation from Board of Directors service in accordance with the Company's Non-Employee Director Deferred Compensation Plan. Read SEC document |
| February 17, 2012 Filed Feb 21, 2012 23:54 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 98.3 | $33.91 Strike: $1.00 | $3,333.35 |
DisclosureSEC source: 0001127602-12-007221 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Former Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,899.25 Underlying: Common Stock · 98.3 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| February 06, 2012 Filed Feb 8, 2012 21:45 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock · Derivative | 5,000 | $46.85 Strike: $46.85 | $234,250.00 |
DisclosureSEC source: 0000310764-12-000022 · edgar.xml · derivative · entry 4 MACMILLAN STEPHEN P · CIK 0001239351 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,000 shares Expires 2016-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Employee stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 10% on each of the first eight anniversaries of the date of grant and 20% on the ninth anniversary of the date of grant. Read SEC document |
| February 06, 2012 Filed Feb 8, 2012 21:45 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 5,000 | $46.85 | $234,250.00 |
DisclosureSEC source: 0000310764-12-000022 · edgar.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 132,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 26, 2012 Filed Jan 31, 2012 00:08 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 12,156 | $0.00 Strike: $32.36 | $0.00 |
DisclosureSEC source: 0001127602-12-003078 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,156 Underlying: Common Stock · 12,156 shares Expires 2022-01-26 F2 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 26, 2013. Read SEC document |
| January 26, 2012 Filed Jan 31, 2012 00:08 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 3,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-12-003078 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,977 F1 · kind: Award of restricted stock units granted under the Texas Instruments 2009 Director Compensation Plan. Read SEC document |
| January 20, 2012 Filed Jan 24, 2012 01:14 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 98.56 | $33.82 Strike: $1.00 | $3,333.30 |
DisclosureSEC source: 0001127602-12-002266 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,771.53 Underlying: Common Stock · 98.56 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| December 16, 2011 Filed Dec 19, 2011 23:19 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 116.91 | $28.51 Strike: $1.00 | $3,333.10 |
DisclosureSEC source: 0001127602-11-032797 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,672.97 Underlying: Common Stock · 116.91 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| November 18, 2011 Filed Nov 21, 2011 22:16 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 109.69 | $30.39 Strike: $1.00 | $3,333.48 |
DisclosureSEC source: 0001127602-11-030292 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,525.42 Underlying: Common Stock · 109.69 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| October 21, 2011 Filed Oct 21, 2011 20:17 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 111.3 | $29.95 Strike: $1.00 | $3,333.44 |
DisclosureSEC source: 0001127602-11-027556 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,415.73 Underlying: Common Stock · 111.3 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| September 16, 2011 Filed Sep 16, 2011 21:44 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 120.29 | $27.71 Strike: $1.00 | $3,333.24 |
DisclosureSEC source: 0001127602-11-025419 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,304.44 Underlying: Common Stock · 120.29 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| August 19, 2011 Filed Aug 24, 2011 12:33 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 131.29 | $25.39 Strike: $1.00 | $3,333.45 |
DisclosureSEC source: 0001127602-11-024134 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,157.81 Underlying: Common Stock · 131.29 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| July 15, 2011 Filed Jul 18, 2011 22:32 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 108.51 | $30.72 Strike: $1.00 | $3,333.43 |
DisclosureSEC source: 0001127602-11-021549 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,026.53 Underlying: Common Stock · 108.51 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| June 17, 2011 Filed Jun 20, 2011 21:03 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 106.43 | $31.32 Strike: $1.00 | $3,333.39 |
DisclosureSEC source: 0001127602-11-019645 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,918.02 Underlying: Common Stock · 106.43 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| May 20, 2011 Filed May 20, 2011 21:03 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 95.32 | $34.97 Strike: $1.00 | $3,333.34 |
DisclosureSEC source: 0001127602-11-017155 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,794.14 Underlying: Common Stock · 95.32 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| April 15, 2011 Filed Apr 18, 2011 21:42 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 96.03 | $34.71 Strike: $1.00 | $3,333.20 |
DisclosureSEC source: 0001127602-11-013120 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,698.82 Underlying: Common Stock · 96.03 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| March 18, 2011 Filed Mar 21, 2011 22:35 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 100.8 | $33.07 Strike: $1.00 | $3,333.46 |
DisclosureSEC source: 0001127602-11-010829 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,602.79 Underlying: Common Stock · 100.8 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| February 18, 2011 Filed Feb 22, 2011 13:30 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 91.37 | $36.48 Strike: $1.00 | $3,333.18 |
DisclosureSEC source: 0001127602-11-006477 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,501.99 Underlying: Common Stock · 91.37 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| February 09, 2011 Filed Feb 11, 2011 21:44 UTC | STRYKER CORP SYK · Entity 369 | GrantCommon Stock · Derivative | 180,805 | $0.00 Strike: $59.70 | $0.00 |
DisclosureSEC source: 0000310764-11-000011 · edgar.xml · derivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,805 Underlying: Common Stock · 180,805 shares Expires 2021-02-08 F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 2006 Long-Term Incentive Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| January 27, 2011 Filed Jan 31, 2011 22:50 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantNQ Stock Option (Right to Buy) · Derivative | 10,002 | $0.00 Strike: $34.63 | $0.00 |
DisclosureSEC source: 0001127602-11-003054 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,002 Underlying: Common Stock · 10,002 shares Expires 2021-01-27 F2 · derivative.exercise_date: The option becomes exercisable in four equal annual installments beginning on January 27, 2012. Read SEC document |
| January 27, 2011 Filed Jan 31, 2011 22:50 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantCommon Stock | 2,887 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-11-003054 · form4.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,887 F1 · kind: Award of restricted stock units granted under the Texas Instruments 2009 Director Compensation Plan. Read SEC document |
| January 21, 2011 Filed Jan 24, 2011 23:17 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 98.3 | $33.91 Strike: $1.00 | $3,333.35 |
DisclosureSEC source: 0001127602-11-002206 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,394.58 Underlying: Common Stock · 98.3 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| January 10, 2011 Filed Jan 10, 2011 21:13 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock · Derivative | 5,000 | $46.85 Strike: $46.85 | $234,250.00 |
DisclosureSEC source: 0000310764-11-000002 · edgar.xml · derivative · entry 4 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 980,000 Underlying: Common Stock · 5,000 shares Expires 2016-02-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Stock option granted pursuant to the Stryker Corporation 1998 Stock Option Plan, exercisable as to 20% on each of the first five anniversaries of the date of grant. Read SEC document |
| January 10, 2011 Filed Jan 10, 2011 21:13 UTC | STRYKER CORP SYK · Entity 369 | Exercise / conversionCommon Stock | 5,000 | $46.85 | $234,250.00 |
DisclosureSEC source: 0000310764-11-000002 · edgar.xml · nonDerivative · entry 1 MACMILLAN STEPHEN P · CIK 0001239351 · Director · Chairman, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,002 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 17, 2010 Filed Dec 17, 2010 22:19 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 102.19 | $32.62 Strike: $1.00 | $3,333.44 |
DisclosureSEC source: 0001127602-10-031162 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,296.28 Underlying: Common Stock · 102.19 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| November 19, 2010 Filed Nov 19, 2010 22:08 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 105.89 | $31.48 Strike: $1.00 | $3,333.42 |
DisclosureSEC source: 0001127602-10-028547 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,177.52 Underlying: Common Stock · 105.89 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| October 15, 2010 Filed Oct 18, 2010 21:53 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 117.74 | $28.31 Strike: $1.00 | $3,333.22 |
DisclosureSEC source: 0001127602-10-025573 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,071.63 Underlying: Common Stock · 117.74 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| September 17, 2010 Filed Sep 21, 2010 20:55 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 133.44 | $24.98 Strike: $1.00 | $3,333.33 |
DisclosureSEC source: 0001127602-10-023613 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,953.89 Underlying: Common Stock · 133.44 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| August 20, 2010 Filed Aug 23, 2010 21:38 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 135.89 | $24.53 Strike: $1.00 | $3,333.38 |
DisclosureSEC source: 0001127602-10-021836 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,820.45 Underlying: Common Stock · 135.89 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| July 16, 2010 Filed Jul 19, 2010 22:11 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 131.23 | $25.40 Strike: $1.00 | $3,333.24 |
DisclosureSEC source: 0001127602-10-019442 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,666.44 Underlying: Common Stock · 131.23 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
| June 18, 2010 Filed Jun 21, 2010 20:44 UTC | TEXAS INSTRUMENTS INC TXN · Entity 2834 | GrantStock Units · Derivative | 130.57 | $25.53 Strike: $1.00 | $3,333.45 |
DisclosureSEC source: 0001127602-10-017656 · form4.xml · derivative · entry 2 MACMILLAN STEPHEN P · CIK 0001239351 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,535.21 Underlying: Common Stock · 130.57 shares Expires not disclosed F1 · derivative.exercise_price: Security converts to common stock on a one-for-one basis. F2 · derivative.exercise_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · derivative.expiration_date: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. F2 · balance_after: Stock units credited under the Texas Instruments 2009 Director Compensation Plan, to be settled in common stock of the Issuer following the reporting person's termination of service as a director of the Issuer. End-of-period holdings include stock units acquired pursuant to the dividend reinvestment provision of the Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.